Rilzabrutinib dose 1 clinical trials

A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

This study is testing a new medicine, rilzabrutinib, for adults with an overactive thyroid caused by Graves' disease, including those with eye problems. We want to see how well it works and if it's safe at two different doses.